Theradiag (France) Analysis
| ALTHE Stock | EUR 0.37 0.03 8.82% |
Theradiag SA is overvalued with Real Value of 0.31 and Hype Value of 0.37. The main objective of Theradiag stock analysis is to determine its intrinsic value, which is an estimate of what Theradiag SA is worth, separate from its market price. There are two main types of Theradiag's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Theradiag's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Theradiag's stock to identify patterns and trends that may indicate its future price movements.
The Theradiag stock is traded in France on Euronext Paris, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in France. Theradiag is usually not traded on Christmas Day, New Year 's Day, Easter Monday, International Workers ' Day, Victory in Europe Day. Theradiag Stock trading window is adjusted to Europe/Paris timezone.
Theradiag |
Theradiag Stock Analysis Notes
About 23.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.19. Theradiag SA had not issued any dividends in recent years. The entity had 367:350 split on the 26th of July 2016. Theraclion SA develops, manufactures, and markets Echopulse ultrasound medical imaging tool for the non-invasive and ambulatory treatment of breast fibroadenomas and benign thyroid nodules to practitioners. The company was founded in 2004 and is based in Malakoff, France. THERACLION operates under Medical Devices classification in France and is traded on Paris Stock Exchange. It employs 22 people. For more info on Theradiag SA please contact the company at 33 1 55 48 90 70 or go to https://www.theraclion.com.Theradiag SA Investment Alerts
| Theradiag SA has some characteristics of a very speculative penny stock | |
| Theradiag SA had very high historical volatility over the last 90 days | |
| Theradiag SA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 1.48 M. Net Loss for the year was (3.76 M) with loss before overhead, payroll, taxes, and interest of (1.4 M). | |
| Theradiag SA has accumulated about 938.86 K in cash with (3.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11. | |
| Roughly 23.0% of the company shares are held by company insiders |
Theradiag Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.16 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Theradiag's market, we take the total number of its shares issued and multiply it by Theradiag's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 25th of November, Theradiag has the Semi Deviation of 2.63, risk adjusted performance of 0.0792, and Coefficient Of Variation of 1080.76. Theradiag technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices.Theradiag SA Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Theradiag middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Theradiag SA. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Theradiag Outstanding Bonds
Theradiag issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Theradiag SA uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Theradiag bonds can be classified according to their maturity, which is the date when Theradiag SA has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Theradiag Predictive Daily Indicators
Theradiag intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Theradiag stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Theradiag Forecast Models
Theradiag's time-series forecasting models are one of many Theradiag's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Theradiag's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Theradiag Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Theradiag prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Theradiag shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Theradiag. By using and applying Theradiag Stock analysis, traders can create a robust methodology for identifying Theradiag entry and exit points for their positions.
Theraclion SA develops, manufactures, and markets Echopulse ultrasound medical imaging tool for the non-invasive and ambulatory treatment of breast fibroadenomas and benign thyroid nodules to practitioners. The company was founded in 2004 and is based in Malakoff, France. THERACLION operates under Medical Devices classification in France and is traded on Paris Stock Exchange. It employs 22 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Theradiag to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Additional Tools for Theradiag Stock Analysis
When running Theradiag's price analysis, check to measure Theradiag's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theradiag is operating at the current time. Most of Theradiag's value examination focuses on studying past and present price action to predict the probability of Theradiag's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theradiag's price. Additionally, you may evaluate how the addition of Theradiag to your portfolios can decrease your overall portfolio volatility.